Prostate News and Research

RSS

Novel radiotracer is an effective option for staging of prostate cancer

The novel radiopharmaceutical 18F-PSMA-1007 is both effective and readily available for detecting malignant prostate cancer lesions, according to research published in the April issue of The Journal of Nuclear Medicine.

11 May 2020

Study discovers inhibition of SARS-CoV-2 entry priming protein by approved drug

The COVID-19 pandemic caused by the severe acute respiratory syndrome -coronavirus 2 (SARS-CoV-2) has spread to most of the world, causing millions of cases and hundreds of thousands of deaths. A new study published on the preprint server bioRxiv* shows that a protease inhibitor drug already approved by the Food and Drug Administration (FDA) could inhibit viral entry.

6 May 2020

New trial platform could help evaluate potential therapies for Parkinson’s disease

Despite 30 years of research, not a single therapy has been found to successfully delay or stop the progression of Parkinson's disease.

6 May 2020

Study provides more insight into the initiation and progression of human cancers

Volume 11, Issue 18 of @Oncotarget Clinical implications of chromatin accessibility assessed by ATAC-seq profiling in human cancers especially in a large patient cohort is largely unknown.

6 May 2020

Activation of estrogen receptor can impede growth of pancreatic cancer cells

Activating the G protein-coupled estrogen receptor - a receptor found on the surface of many normal and cancer tissues - has been shown to stop pancreatic cancer from growing, but may also make tumors more visible to the immune system and thus more susceptible to modern immunotherapy.

4 May 2020

Cancer patients with COVID-19 more likely to die from the disease

People with cancer who develop COVID-19 are much more likely to die from the disease than those without cancer, according to physician-researchers at Montefiore Health System and Albert Einstein College of Medicine.

2 May 2020

Lipo-ImmunoTech receives grant to develop novel adoptive cell therapy technology for cancer

Lipo-ImmunoTech, LLC, a startup based in Charleston, South Carolina, recently received a Phase I Small Business Technology Transfer grant of just over $224,000 to continue to develop its novel adoptive cell therapy technology for cancer.

2 May 2020

Study provides insight into regenerative potential of prostate gland

The standard treatment for men with advanced prostate cancer is androgen-deprivation therapy. Androgens are hormones that fuel prostate cell growth; removing them with either drugs or surgery causes the prostate gland to shrink by 90%.

30 Apr 2020

Study finds abnormal alternative RNA splicing patterns in aggressive prostate cancer

Aggressive forms of prostate cancer don't act the way they should, hanging on to genetic materials called introns that should be thrown away, a new six-year study led by Dean Tang, Ph.D., and Song Liu, Ph.D., of Roswell Park Comprehensive Cancer Center has revealed.

30 Apr 2020

Drug reduces risk of men with pedophilic disorder sexually abusing children

A drug that lowers levels of the male hormone testosterone in the body reduces the risk of men with pedophilic disorder sexually abusing children, a study from Karolinska Institutet published today in the journal JAMA Psychiatry shows.

29 Apr 2020

Higher levels of specific gene can indicate better prognosis in prostate cancer

The most common form of cancer in older men is prostate cancer. In many cases the tumor grows slowly and can be treated effectively, but it is sometimes more aggressive and becomes terminal.

23 Apr 2020

Study finds NCCN Guidelines for Patients listed among the most trustworthy online resources

A recently-published study from researchers in Australia and South Africa found the NCCN Guidelines for Patients to be among the most trustworthy resources for patients and caregivers seeking information online about prostate cancer.

21 Apr 2020

Prostate cancer mortality rates predicted to fall in the EU but rise in Poland

Death rates from prostate cancer are predicted to fall in 2020 in the EU, largely due to better diagnosis and treatment, according to new research published in the leading cancer journal Annals of Oncology today (Monday).

20 Apr 2020

Death rates from prostate cancer predicted to decline overall in EU

Death rates from prostate cancer are predicted to fall in 2020 in the EU, largely due to better diagnosis and treatment.

17 Apr 2020

A 'toolbox' for biomarker discovery of urological cancers

Researchers from Ghent University, Belgium, together with researchers from the University of Turku, Finland, have developed a new method for biomarker discovery of urological cancers.

16 Apr 2020

Study demonstrates the benefits of genomic risk assessment in preventing common diseases

A new Finnish study demonstrated the benefits of large-scale genomic information in estimating the risk of onset for cardiac diseases, diabetes and common cancers.

10 Apr 2020

Recommendations for keeping cancer patients, providers safe during COVID-19 pandemic

The National Comprehensive Cancer Network--an alliance of leading cancer centers--is continuing to share new resources for optimal cancer management amid new and changing challenges related to the Coronavirus Disease 2019.

10 Apr 2020

Mathematical model can predict patient outcomes to adaptive prostate cancer therapy

Prostate cancer is the most common malignancy among men in the United States. It is also the second most common cause of cancer-related deaths. Despite improved treatments for prostate cancer, many patients with advanced disease eventually develop drug resistance.

9 Apr 2020

Purdue scientists aim to use protein power to halt tumor growth

In 2018, approximately 324,000 men died from cancer in the United States. The combination of lung cancer, prostate cancer and colorectal cancer equated to half of those deaths.

7 Apr 2020

'Smart toilet' looks for signs of disease

A Stanford study published in the journal Nature Biomedical Engineering in April 2020 reports the development of a new kind of toilet that can pick up signs of an extensive range of diseases, from molecules in stool and urine. This could be extremely useful in repeatedly and inexpensively screening high-risk groups for certain conditions, including those for which a genetic tendency is possible – such as prostate cancer or certain kinds of kidney cancer.

6 Apr 2020

Prostate News and Research

Novel radiotracer is an effective option for staging of prostate cancer

Study discovers inhibition of SARS-CoV-2 entry priming protein by approved drug

New trial platform could help evaluate potential therapies for Parkinson’s disease

Study provides more insight into the initiation and progression of human cancers

Activation of estrogen receptor can impede growth of pancreatic cancer cells

Cancer patients with COVID-19 more likely to die from the disease

Lipo-ImmunoTech receives grant to develop novel adoptive cell therapy technology for cancer

Study provides insight into regenerative potential of prostate gland

Study finds abnormal alternative RNA splicing patterns in aggressive prostate cancer

Drug reduces risk of men with pedophilic disorder sexually abusing children

Higher levels of specific gene can indicate better prognosis in prostate cancer

Study finds NCCN Guidelines for Patients listed among the most trustworthy online resources

Prostate cancer mortality rates predicted to fall in the EU but rise in Poland

Death rates from prostate cancer predicted to decline overall in EU

A 'toolbox' for biomarker discovery of urological cancers

Study demonstrates the benefits of genomic risk assessment in preventing common diseases

Recommendations for keeping cancer patients, providers safe during COVID-19 pandemic

Mathematical model can predict patient outcomes to adaptive prostate cancer therapy

Purdue scientists aim to use protein power to halt tumor growth

'Smart toilet' looks for signs of disease

What to know about prostate cancer eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News